19 October 2018Americas

I-MAK: saving lives by curing the patent system

More than 85% of Americans diagnosed with chronic hepatitis C will not receive treatment this year. It’s the same story the world over—the UK is rationing these drugs and France also has problems. These are the claims of Tahir Amin, co-founder of non-profit group the Initiative for Medicines, Access & Knowledge (I-MAK).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk